These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35861202)

  • 1. Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression.
    Scott F; Hampsey E; Gnanapragasam S; Carter B; Marwood L; Taylor RW; Emre C; Korotkova L; Martín-Dombrowski J; Cleare AJ; Young AH; Strawbridge R
    J Psychopharmacol; 2023 Mar; 37(3):268-278. PubMed ID: 35861202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation treatment in major depressive disorder: focus on aripiprazole.
    Nelson JC; Pikalov A; Berman RM
    Neuropsychiatr Dis Treat; 2008 Oct; 4(5):937-48. PubMed ID: 19183784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of eight enhanced therapies for treatment-resistant depression: A systematic review and network meta-analysis of RCTs.
    Guo Q; Guo L; Wang Y; Shang S
    Psychiatry Res; 2024 Jun; 339():116018. PubMed ID: 38924903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major depressive disorder after heart transplantation with partial response to antidepressant therapy and remission with aripiprazole augmentation: A case report.
    Nakamura T; Kuraishi Y; Ohya D; Kimura K; Sasayama D; Washizuka S
    Neuropsychopharmacol Rep; 2024 Jun; ():. PubMed ID: 38923862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Old treatments new outcomes-augmentation treatments for depression.
    Nuñez NA; Joseph B; Vazquez GH
    Front Psychiatry; 2024; 15():1384641. PubMed ID: 38495903
    [No Abstract]   [Full Text] [Related]  

  • 6. A Review of Psychostimulants for Adults With Depression.
    Pary R; Scarff JR; Jijakli A; Tobias C; Lippmann S
    Fed Pract; 2015 Apr; 32(Suppl 3):30S-37S. PubMed ID: 30766117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis.
    de A Simoes Moreira D; Gauer LE; Teixeira G; Fonseca da Silva AC; Cavalcanti S; Quevedo J
    J Affect Disord; 2023 Jun; 330():227-238. PubMed ID: 36907464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.
    Jha MK; Mathew SJ
    Am J Psychiatry; 2023 Mar; 180(3):190-199. PubMed ID: 36855876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel and emerging treatments for major depression.
    Marwaha S; Palmer E; Suppes T; Cons E; Young AH; Upthegrove R
    Lancet; 2023 Jan; 401(10371):141-153. PubMed ID: 36535295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy for Treatment-Resistant Depression: Antidepressants and Atypical Antipsychotics.
    Vas C; Jain A; Trivedi M; Jha MK; Mathew SJ
    Psychiatr Clin North Am; 2023 Jun; 46(2):261-275. PubMed ID: 37149344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine vs Electroconvulsive Therapy for Major Depressive Episode: A Systematic Review and Meta-analysis.
    Menon V; Varadharajan N; Faheem A; Andrade C
    JAMA Psychiatry; 2023 Jun; 80(6):639-642. PubMed ID: 37043224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability.
    Smith-Apeldoorn SY; Veraart JK; Spijker J; Kamphuis J; Schoevers RA
    Lancet Psychiatry; 2022 Nov; 9(11):907-921. PubMed ID: 36244360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esketamine and Psilocybin-The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review.
    Psiuk D; Nowak EM; Dycha N; Łopuszańska U; Kurzepa J; Samardakiewicz M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketamine in neuropsychiatric disorders: an update.
    Johnston JN; Kadriu B; Kraus C; Henter ID; Zarate CA
    Neuropsychopharmacology; 2024 Jan; 49(1):23-40. PubMed ID: 37340091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review.
    Kwaśny A; Włodarczyk A; Ogonowski D; Cubała WJ
    Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression.
    Lenze EJ; Mulsant BH; Roose SP; Lavretsky H; Reynolds CF; Blumberger DM; Brown PJ; Cristancho P; Flint AJ; Gebara MA; Gettinger TR; Lenard E; Miller JP; Nicol GE; Oughli HA; Pham VT; Rollman BL; Yang L; Karp JF
    N Engl J Med; 2023 Mar; 388(12):1067-1079. PubMed ID: 36867173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review.
    Jollant F; Colle R; Nguyen TML; Corruble E; Gardier AM; Walter M; Abbar M; Wagner G
    Ther Adv Psychopharmacol; 2023; 13():20451253231151327. PubMed ID: 36776623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines' recommendations for the treatment-resistant depression: A systematic review of their quality.
    Gabriel FC; Stein AT; Melo DO; Fontes-Mota GCH; Dos Santos IB; Rodrigues CDS; Dourado A; Rodrigues MC; Fráguas R; Florez ID; Correia DT; Ribeiro E
    PLoS One; 2023; 18(2):e0281501. PubMed ID: 36745622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral ketamine for depression: An updated systematic review.
    Meshkat S; Haikazian S; Di Vincenzo JD; Fancy F; Johnson D; Chen-Li D; McIntyre RS; Mansur R; Rosenblat JD
    World J Biol Psychiatry; 2023; 24(7):545-557. PubMed ID: 36651238
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of esketamine in the treatment of patients with oral antidepressant-resistant depression: systematic review and meta-analysis.
    Floriano I; Silvinato A; Bernardo WM
    Rev Assoc Med Bras (1992); 2023; 69(6):e2023D696. PubMed ID: 37377288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.